Preventing ICU Subsyndromal Delirium Conversion to Delirium With Haloperidol

NCT01174290 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Subsyndromal Delirium

Interventions

DRUG: Haloperidol decanoate
DRUG: Placebo

Sponsor

Northeastern University

Collaborators

[object Object]